Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.
about
Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancerReactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cellsThe receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteinsSignification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.HIC1 interacts with and modulates the activity of STAT3.Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinomaHIC1 (hypermethylated in cancer 1) SUMOylation is dispensable for DNA repair but is essential for the apoptotic DNA damage response (DDR) to irreparable DNA double-strand breaks (DSBs).Central and peripheral nervous systems: master controllers in cancer metastasis.BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair.HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy.Downregulation of hypermethylated in cancer-1 by - promotes adriamycin resistance in breast cancer cells
P2860
Q28539229-2EFB4BB1-7D9C-446E-BBA7-0933FD9FE6EAQ34582453-52AC5D1C-0BDD-460A-9D4C-5D50E4502C9EQ35773939-BFF8F5A7-D881-498F-9105-1C62293B0FDFQ35880084-3166A21A-D817-4C19-8F3C-A244F0231040Q36284970-AECCEA0D-3F54-4FE4-8FD5-69237E308B75Q36931136-3ABDD63A-3EF1-4706-9F91-59638BAFB7C7Q37126191-6DDF2978-D8C8-43A6-9B28-FB4FDE85E593Q37327489-51101987-AA17-46DD-851B-CB6A2F917900Q37708962-342F0BDD-D5FE-4E1F-B53D-935BA6B61AC5Q37709402-0A4B0CA9-2477-444B-A72E-FCEC474D7F34Q38106901-DBBE9B5A-9538-47D7-B51D-772DAC154F51Q39192269-1AC477CC-E64A-426D-9266-3CEB6C5B9792Q39794371-80AD3B1B-9624-49EF-A281-4E99C2A1F9DFQ40250355-622FAD25-DE6E-4774-A214-E667EC9DB7B5Q58765211-C7423A4B-FD20-466C-A75D-DF67F88EE3C0
P2860
Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@ast
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@en
type
label
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@ast
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@en
prefLabel
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@ast
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@en
P2093
P2860
P356
P1476
Loss of Hypermethylated in Can ...... eceptor (ADRB2) misregulation.
@en
P2093
Albin Pourtier
Brian R Rood
Bénédicte Foveau
Gaylor Boulay
Ingrid Loison
Nicolas Malaquin
P2860
P304
P356
10.1074/JBC.M111.304287
P407
P577
2011-12-22T00:00:00Z